The phase 2 human clinical trial of the Oxford COVID-19 vaccine candidate in the country by Pune-based Serum Institute of India (SII) is set to begin today.

from NDTV News - Topstories https://ift.tt/2FN96yE
https://ift.tt/eA8V8J